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 Insulin stimulated glucose uptake is a critical component of glucose 
homeostasis. The studies presented here show that myosin IIA is actively 
recruited to the plasma membrane upon insulin stimulation. I also show that 
inhibiting the interaction of myosin II with actin or inhibiting the activation of 
myosin II by myosin light chain kinase resulted in myosin IIA remaining localized 
to the perinuclear region of 3T3-L1 adipocytes. Based on my findings I 
hypothesized that the localization and activation of myosin IIA is regulated by the 
activation of the insulin signaling pathway. The studies presented here reveal 
underlying interactions and mechanisms affecting insulin stimulated glucose 
uptake providing important information that can be used to optimize current 
treatments or develop new treatments for type II diabetes. 
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CHAPTER I
INTRODUCTION
Type II diabetes mellitus is a major public health issue and is a 
contributing factor to many other health problems such as blindness, heart 
disease, renal failure and non-traumatic amputations. Type II diabetes accounts 
for 90 to 95% of all diagnosed cases of diabetes and affects more than 6% of the 
adult population in the US. Some contributing factors involved in the 
development of type II diabetes are aging, obesity, family history of diabetes, 
prior history of gestational diabetes, impaired glucose tolerance, physical 
inactivity, race and ethnicity. While aging is a contributing factor to the 
development of type II diabetes, recent studies have shown that there is a rise of 
type II diabetes in children. Recent reports from the American Diabetes 
Association indicate that up to 45% of children diagnosed with diabetes have 
type II diabetes. 
Type II diabetes is a disease that affects blood glucose levels due to a 
decreased response to insulin. Type II diabetes begins as insulin resistance, a 
disorder in which the cells do not respond to normal insulin levels. As insulin 
levels increase to facilitate glucose uptake, the pancreatic beta cells cease to 
function properly and gradually lose the ability to produce insulin.  
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 The prevalence of this disease in our society identifies a need to 
understand all the factors involved in the development of type II diabetes. 
Identifying factors on the molecular level will contribute to our further 
understanding of this disease state and the development of potential treatments. 
 This study is an investigation of the cellular mechanisms involved in 
insulin dependent glucose uptake. My previous studies have shown that insulin 
stimulated glucose uptake in mature 3T3-L1 adipocytes was impaired by the 
inhibition of non muscle myosin II activity [1]. My current investigation of myosin II 
isoforms and their role during insulin stimulated glucose uptake identifies 
underlying factors regulating the dynamic cellular processes responsible for 
glucose homeostasis. In turn these results could offer insight for new treatments 
related to type II diabetes.
 
Insulin stimulated glucose uptake
 The binding of insulin to its receptor initiates a cascade of events critical 
for glucose uptake. The insulin receptor is a transmembrane tyrosine kinase 
receptor consisting of a series of two exofacial α subunits, which bind insulin and 
two plasma membrane bound β tyrosine kinase subunits. Activation of the 
receptor results in its auto-phosphorylation and the recruitment and 
phosphorylation of insulin receptor substrates (IRS). This then activates 
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Figure 1. Representation of insulin stimulated GLUT4 translocation.
phosphatidylinositol-3 kinase (PI3 kinase) which activates both the serine / 
threonine protein kinase Akt / PKB along with the atypical protein kinase C 
(aPKC) [2, 4]. The activation of Akt / PKB and / or aPKC stimulates the 
translocation of vesicles containing the insulin responsive glucose transporter 4 
(GLUT4) from intracellular “pools” to the plasma membrane (Fig. 1) [2, 4]. Insulin 
also activates other PI3 kinase independent pathways which facilitate glucose 
uptake for example the MAPK and Cbl pathways [2, 4, and 6].
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A functional role for the actin cytoskeleton in adipocytes
Mature differentiated adipocytes do not contain a stress fiber matrix to 
provide structural support; instead mature adipocytes have a distinct layer of 
cortical actin adjacent to the plasma membrane [7]. The actin cytoskeleton in 
3T3-L1 adipocytes consist of a network of filamentous actin (F - actin) [7]. The 
actin cytoskeleton gives the cell its structural integrity, but also acts as a network 
of tracks for vesicle transport and as a barrier to either endocytosis or exocytosis 
at the plasma membrane. The actin “tracks” have been shown to facilitate 
translocation of GLUT4 containing vesicles from intracellular pools to the plasma 
membrane in adipocytes [7]. One of the events that have to occur for GLUT4 
vesicle docking and fusion is that the actin layer at the plasma membrane has to 
be reorganized. The structural integrity provided by the cortical actin layer is 
separated at specific regions at the plasma membrane to facilitate proper 
docking and fusion of GLUT4 vesicles to the plasma membrane [7]. In both 
muscle and adipose tissue the remodeling of cortical actin in has been shown to 
be regulated by the activation of the motor protein myosin II [8]. Investigation of 
myosin II and the actin cytoskeleton may further our understanding of GLUT4 
vesicle fusion and thus, further our understanding of insulin stimulated glucose 
uptake. 
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Non-muscle myosin II
 Non-muscle myosin II is a cytoplasmic myosin that is responsible for 
cytokinesis and the structural integrity of many cell types. Three isoforms of 
myosin II have been identified that carry out similar functions which do not 
overlap. Myosin II is expressed in most tissues in varying amounts although; 
in some tissues only one isoform is expressed such as chicken intestinal 
epithelium and human blood platelets [11, 25]. Previous studies have 
identified distinct patterns of myosin II isoform localization in several cell 
types, such as the localization patterns of myosin IIA and myosin IIB in the 
edge of migrating endothelial [11]. Some other relevant examples in other cell 
types are the localization of myosin IIA and IIB in cultured neurons at actin 
rich regions of neurite growth cones [26]. Another example is the localization 
of myosin IIA at dynamic regions of cytoskeletal compartments of osteoclasts 
where as the localization of myosin IIB remains somewhat constant 
throughout different osteoclast activation cycles [29].  
 Myosin II exists as a hexameric structure consisting of two heavy 
chains (MHC), two regulatory light chains (RLC) and two essential light chains 
(ELC) (Fig. 2). The heavy chains are structurally oriented to form a globular 
head domain that expresses binding sites for ATP and actin. 
 Myosin II motor activity and parallel filament assembly are regulated by 
the phosphorylation of residues localized on the RLCs [10, 24].
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Three kinases have thus far been identified that phosphorylate the regulatory 
light chains of myosin II: the Ca2+ / calmodulin dependent myosin light chain 
kinase (MLCK), Rho kinase (RHOK) and p21 activated kinase [10, 24]. 
Phosphorylation of the regulatory light chains in a Ca2+ / calmodulin dependent 
manner via myosin light chain kinase is very specific in initiating the binding of 
myosin II to filamentous actin [33 - 36]. The regulatory light chain of myosin II is 
the only known substrate for myosin light chain kinase [10].
Figure 2. Representation of the myosin II hexameric structure. Two 
heavy chains in a coiled coil orientation, black. Two essential light chains, 
green, and two regulatory light chains, blue. Globular terminal head region, 
red, carboxy terminal tail. Adapted from [10] Current Opinions in Cell Biology 
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Myosin II and insulin stimulated glucose uptake
My recent studies have shown a direct link between myosin II function and 
insulin stimulated glucose uptake [1]. This was accomplished by utilizing the 
specific myosin II inhibitor, blebbistatin. Blebbistatin is a non competitive inhibitor 
of myosin II ATPase activity. 
 The data presented in Figure 3 is from a series of glucose uptake assays 
from my recent publication identifying a novel role for myosin II during insulin 
Fig. 3 Inhibition of myosin II impairs insulin-
stimulated glucose uptake in 3T3-L1 adipocytes. 
Adipocytes were serum starved in the presence of 
vehicle (0.1% DMSO) or 100 µM blebbistatin, and then 
stimulated with 100 nM insulin for 10 min and assayed 
for [14C]2-deoxy-d-glucose uptake in the presence of 
vehicle or 100 µM blebbistatin. Glucose uptake was 
calculated as disintegrations per mg protein and 
expressed as percent of the vehicle control. Results 
are means ± SEM of three independent experiments.
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stimulated glucose uptake [1]. We observed approximately a 75 % inhibition of 
insulin stimulated glucose uptake in the blebbistatin group compared to the 
insulin controls. These findings are the first to identify a functional role for myosin 
II activity in insulin stimulated glucose uptake.
Basal Insulin Insulin + Bleb
Whole 
Cells
Plasma 
Membrane
Figure 4. Insulin-stimulated GLUT4 translocation 
was not affected by treatment with blebbistatin. 
Adipocytes were treated according to the glucose 
uptake protocol as described in materials and methods, 
and GLUT4 protein was visualized by 
immunofluorescence using a GLUT4-specific antibody. 
GLUT4 localization was assayed in whole cells (top 
panel) as well as plasma membrane sheets (bottom 
panel) in the basal condition and after stimulation with 
insulin in the presence and absence of 100 µM
blebbistatin. The results are representative images from 
three independent experiments.
 Since GLUT4 translocation is critical for insulin stimulated glucose uptake, 
I wanted to determine whether GLUT4 translocation to the plasma membrane 
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during insulin stimulated glucose uptake was altered by inhibiting myosin II 
activity. 3T3-L1 adipocytes were incubated in the presence of 100 µm 
blebbistatin. The cells were then stimulated with insulin and assayed for GLUT4 
localization using confocal microscopy (Fig. 4) [1]. My studies show that GLUT4 
translocation to the plasma membrane was not affected by the inhibition of 
myosin II activity. GLUT4 vesicles can be qualitatively identified in the insulin 
control and insulin plus blebbistatin treatment (Fig. 4). When myosin II activity is 
inhibited, insulin stimulated glucose uptake is impaired yet GLUT4 vesicles still 
translocated to the plasma membrane. This suggests that myosin II is involved in 
some downstream event in GLUT4 mediated glucose uptake such as GLUT4 
vesicle fusion with the plasma membrane. Previous studies have shown that 
contraction of the actin cytoskeleton in rat chromaffin cells and human MRC-5 
fibroblast can lead to localized remodeling at the cellular cortex [30,31] The 
dynamic process of actin remodeling may be responsible for the docking and 
fusion of GLUT4 with the plasma membrane. Taken together these results reveal 
that there is a relationship between GLUT4 mediated glucose uptake and the 
activity of myosin II. 
 In my previous publication, two myosin II isoforms were identified in 3T3-
L1 adipocytes by western blot analysis (Fig. 5). In other cell types where both 
isoforms have been shown to be expressed, distinct localization patterns have 
been identified where one isoform may only occupy a specific intracellular space 
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at a given time. An example of this pattern has been identified in migrating 
human MRC-5 fibroblasts where myosin IIA localized to the lamellipodia 
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Figure 5. Effect of blebbistatin on myosin II levels in 3T3-
L1 adipocytes. Cells were pre-treated with 0.1% DMSO 
vehicle or 100 µM blebbistatin and were then left untreated 
(basal) or stimulated with 100 nM insulin for 10 min. Cell 
lysates were analyzed by SDS-PAGE, blotted to membrane, 
and then probed with antibodies against myosin IIA, and 
myosin IIB, as indicated. The results are representative of 
three individual experiments
extensions and throughout the posterior region of the cells with myosin IIB. 
Similar patterns have been revealed in activated osteoclast where myosin IIA 
was shown to localize in cytoskeletal compartments of polarized and non-
polarized osteoclast where myosin IIB was not found in these dynamic regions 
[29, 30]. Since two myosin isoforms have been identified in 3T3-L1 adipocytes it 
could be postulated based on previous findings in other cell types expressing 
both myosin IIA and IIB, that the two have distinct intracellular localization 
patterns during the dynamic process of insulin stimulated glucose uptake. With 
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the identification of two myosin II isoforms in 3T3-L1 adipocytes it is important to 
identify the localization patterns of the two myosin isoforms prior to and during 
insulin stimulated glucose uptake. It is also of interest to determine whether the 
myosin II isoforms are recruited to facilitate glucose uptake and which of the 
isoforms is being activated during insulin stimulated glucose uptake. 
Based on previous findings revealing distinct patterns of myosin II isoform 
localization during dynamic cellular processes, it can be postulated that the same 
pattern of distribution may be revealed in 3T3-L1 adipocytes during insulin 
stimulated glucose uptake with insulin signaling regulating the process [10 – 12 
and 30]. I hypothesize that myosin II localization and activity are regulated during 
insulin stimulated glucose uptake in 3T3-L1 adipocytes
Previous studies have shown isoform specific localization patterns of 
myosin IIA and B in various cell types [9 – 12 and 29 - 30]. In my previous work I 
identified that both myosin IIA and myosin IIB are expressed in 3T3-L1 
adipocytes. Since both of these isoforms are expressed in 3T3-L1 adipocytes 
and inhibition of myosin II activity impairs insulin stimulated glucose uptake but 
not the recruitment of GLUT4 to the plasma membrane, it is important to 
determine where the isoforms are localized in the basal state and during insulin 
stimulation to understand their role during insulin stimulated glucose uptake [1, 
24]. Based on the examples of the localization patterns of myosin II in other cell 
types expressing both isoform IIA and IIB I hypothesize that the IIA isoform will 
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be localized near the perinuclear region and the IIB isoform will be localized to 
the plasma membrane.  
 Insulin stimulation assays were conducted and myosin II isoforms were 
examined using isoform specific antibodies to either myosin IIA or myosin IIB. 
Confocal microscopy was utilized to determine the localization of the two 
isoforms in 3T3-L1 adipocytes prior to and after insulin stimulation. 
I expect to see distinct localization patterns of the two isoforms in the 
basal state and insulin stimulated state based on previous studies in other cell 
types. I also predict that myosin IIA will be recruited to the plasma membrane 
upon insulin stimulation since previous studies have shown that myosin IIA can 
re-localize upon exposure to various stimuli [10]  
My previous studies have shown that inhibition of myosin II activity 
significantly decreases GLUT4 mediated insulin stimulated glucose uptake 
although there is no effect on GLUT4 translocation to the plasma membrane (Fig. 
3 and 4)  [1]. In previous studies investigating the localization of myosin IIA and 
myosin IIB during dynamic cellular processes such as the migration of 
endothelial cells and activation stages of osteoclast, it has been shown that 
myosin IIA was localized primarily in dynamic regions of activity [25, 29]. If 
myosin IIA is recruited to the plasma membrane, a dynamic region of activity, it is 
of interest to determine whether myosin IIA is recruited prior to, with or after 
GLUT4 vesicle recruitment to the plasma membrane. 
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I predict that the recruitment of myosin II to the plasma membrane will be 
specific and not random. This prediction is based on my findings revealing that 
myosin IIA is actively recruited during insulin stimulated glucose uptake and 
findings from previous investigations revealing that myosin IIA is localized at 
specific regions in various cell types [9 - 11, 25, 26, 30 and 32]. I hypothesize 
that myosin IIA will be recruited to the plasma membrane at sites close to GLUT4 
vesicles after the insulin signaling pathway is activated.  
Using cultured 3T3-L1 adipocytes, confocal microscopy assays were 
performed to determine the localization of myosin IIA and GLUT4 at various time 
points after insulin stimulation. These assays reveal the temporal relationship 
between GLUT4 vesicle translocation and myosin IIA recruitment during insulin 
stimulated glucose uptake.  
I expect to see specific and not random localization patterns of myosin IIA 
recruitment to the plasma membrane after insulin stimulation. I also predict that if 
myosin IIA is facilitating glucose uptake, then the recruitment of myosin IIA must 
be targeted to specific regions at the plasma membrane where GLUT4 has 
translocated to and not to random sites. 
My previous work was the first to reveal that 3T3-L1 adipocytes express 
both myosin IIA and IIB isoforms [1]. Since both isoforms are expressed in 3T3-
L1 adipocytes and inhibition of myosin II activity impairs glucose uptake it is 
important to identify if insulin is regulating the activity of one or both of the 
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isoforms. Myosin II activity is stimulated by the phosphorylation of the regulatory 
light chain. Phosphorylation of the RLC can be controlled by three kinases: 
myosin light chain kinase (MLCK), Rho kinase (Rhok) or the p21 activated kinase 
[10]. As shown in my previous study, insulin stimulated glucose uptake was 
dependent on myosin II activity [1]. I hypothesize that there will be a significant 
increase in the phosphorylation of the RLC of myosin II during insulin stimulation.  
Activated myosin II was determined by immunoprcipitation assays. Myosin 
IIA and myosin IIB were immunoprecipitated and immunoblotted to detect the 
regulatory light chain and phosphorylation status of the regulatory light chain. 
Antibodies specific for myosin IIA, myosin IIB, RLC and phosphorylated RLC 
were used. 
Based on findings from my previous study showing that the inhibition of 
myosin II impairs glucose uptake but not GLUT4 translocation, I predict that the 
regulation of myosin II activity via phosphorylation of the regulatory light chain is 
dependent on insulin signaling, following the proposed recruitment and 
localization patterns of myosin IIA I predict that myosin IIA activity will be 
regulated by insulin.
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CHAPTER II
MATERIALS AND METHODS
 Materials for this study were obtained from the following: Cell culture 
reagents were purchased from Gibco (Grand Island, NY). Insulin was obtained 
from Roche Diagnostics (Indianapolis, IN). Dexamethasone, 3-isobutyl-1-methyl-
xanthine, Triton X-100, ML-7 and myosin IIA antibody was purchased from 
Sigma-Aldrich (St. Louis, MO). Blebbistatin was obtained from Calbiochem (San 
Diego, CA). GLUT4 antibody (C-20) and Ag + agarose beads were purchased 
from Santa Cruz Biotechnology (Santa Cruz, CA). Myosin IIA and Myosin IIB 
antibodies were obtained from Covance (Berkeley, CA). Alexa Fluor 488 and 
594, donkey anti-goat IgG, goat anti-rabbit IgG and Image-iT FX Signal Enhancer 
were purchased from Molecular Probes (Eugene, OR). Protein assay kit, Immuno 
- Star - AP chemiluminescent kit and Goat IgG2 alkaline phosphatase conjugated 
antibody was obtained from Bio-Rad Laboratories (Hercules, CA). Mounting 
media was purchased from DAKO Cytomation (Carpinteria, CA
Cell culture
  3T3-L1 pre-adipocytes were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 10% calf serum (CS) until confluent and maintained 
for an additional 2 days (until day 0). Differentiation was induced on day 0 by the 
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addition of 0.5 mM methylisobutylxanthine (M), 0.5 µM dexamethasone (D), 10 
µg / ml insulin (I), and 10% fetal bovine serum (FBS) in DMEM. On day 3, the 
MDI medium was replaced with DMEM/10% FBS, and changed every two days 
thereafter until analysis. Cytoplasmic triglyceride droplets became abundant 
between days 4 and 5, and by day 7, cells were fully differentiated [15].
Insulin stimulation assays and timed course insulin stimulation assays
  3T3-L1 adipocytes were differentiated as previously described [15]. 
Adipocytes were cultured in 10 cm tissue culture plates for lysates analysis. 3T3-
L1 pre-adipocytes were cultured in 10 cm plates containing cover slips to be 
used for confocal microscopy assays. Insulin stimulation assays were carried out 
on mature adipocytes using the following protocol: Mature adipocytes (day 9-12) 
were serum starved for 4 hours in the presence of 0.1% DMSO (vehicle) or 100 
µM blebbistatin or 10 µM ML-7. Adipocytes were then washed twice with 37°C 
Krebs–Ringer Phosphate (KRP) buffer (pH 7.4) containing 128 mM NaCl, 4.7 
mM KCl, 1.65 mM CaCl2, 2.5 mM MgSO4, and 5 mM Na2HPO4, and then placed 
in KRP buffer containing vehicle or either 100 µM blebbistatin or 10 µM ML-7. 
Samples were untreated (basal) or treated with 100 µM insulin for 10 min. The 
time course insulin stimulation assays were treated as described above and 
stimulated with 100 µM insulin up to the following time points; 2 minutes, 4 
minutes, 6 minutes and 10 minutes. Cells were washed 3 times with cold 1x 
PBS. Cells were either lysed or fixed as described below. 
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Immunofluorescent staining for confocal microscopy assays  
 Whole cell multiple immunostaining procedures were used to assay for the 
myosin II isoforms and GLUT4. Previously treated cells from the insulin 
stimulation assay were fixed in a 2% paraformaldehyde solution for 5 minutes 
and washed 3x with 1x PBS. The samples were then permeabilized with a 0.25% 
Triton X-100 solution for 5 min at 4 C. Following permeabliazation, the samples 
are washed 3x in 1x PBS. The samples were then incubated for 1 hour in a 
solution containing a GLUT4 antibody (Santa Cruz Biotechnology; Santa Cruz, 
CA) and myosin IIA antibody or myosin IIB antibody (Covance; Berkeley, CA). 
After the primary incubation the samples were washed 3x with 1x PBS.  The cells 
were then sequentially incubated with an anti-goat and anti-rabbit Alexa-fluor 488 
and 594 labeled antibodies (Molecular Probes; Eugene, OR). The samples were 
then washed 4x with 1x PBS. Samples were viewed using a FLUOVIEW FV5OO 
laser scanning confocal microscopy system. An image was collected at the top, 
center and base of the cells at specific regions of interest. The images were then 
compiled using  FLUOVIEW software. 
Immunoblot analysis
 After insulin stimulation cells were washed three times in cold PBS and 
placed immediately in a lysis buffer containing 25 mM Hepes, pH 7.4, 1% 
Nonidet P-40, 100 mM NaCl, 2% glycerol, 5 mM NaF, 1 mM EDTA, 1 mM 
Na3VO4, 1 mM NaPPi, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg / ml 
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aprotinin, 5 mg / ml leupeptin, and 5 mg/ml pepstatin. Lysates were gently mixed 
for 20 min at 4°C and then centrifuged at 6000g for 20 min at 4°C to pellet 
insoluble material. The supernatants were retained for subsequent analysis. 
Protein concentrations of whole-cell lysates were determined using the Bradford 
dye binding method (Bio-Rad; Hercules, CA). Samples were then heated for 5 
min at 95 C, separated by 12% SDS–PAGE, transferred to Immobilon-P 
membranes (Millipore), and analyzed by immunoblotting. Immunoblots were 
developed with an ECL kit and exposed to x-ray film for detection. 
Immunoprecipitation
 Antibodies were added at (3 µg / ml) to whole-cell lysates (1 mg) for each 
subsequent assay. Lysates were then agitated overnight (± 16 hrs) at 4°C. 
Agarose beads (protein A / G PLUS–agarose beads; Santa Cruz Biotechnology,) 
were mixed with the immunoprecipitates and agitated for 1 h at 4 °C. 
Immunoprecipitates were recovered by centrifugation at 2500g and washed three 
times with ice cold lysis buffer. Immunoprecipitated proteins were then dissolved 
in 2× Laemmli buffer, heated for 5 min at 95 C, subjected to 10% SDS–PAGE, 
and transferred to Immobilon-P membranes (Millipore). Membranes were 
incubated with the indicated primary antibodies and visualized by enhanced 
chemiluminescence.
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CHAPTER III
RESULTS
Myosin II isoforms exhibit distinct localization patterns during insulin stimulated 
glucose uptake in adipocytes
 Previous studies have revealed distinctive localization patterns for the two 
isoforms of myosin II (IIA and IIB) depending on cell type and cellular context [9 - 
12, 25 and 26]. In my previous study I identified that 3T3-L1 adipocytes express 
both myosin IIA and IIB [1]. These studies determined first, the localization 
pattern of the myosin II isoforms in the basal state and also whether the 
observed patterns of isoform localization were altered in the presence of insulin. I 
conducted insulin stimulation assays and then examined the localization of 
myosin IIA and IIB using isoform specific antibodies and confocal microscopy
I observed that under basal conditions, myosin IIA is localized primarily to 
the perinuclear region in adipocytes but is recruited to the plasma membrane 
upon insulin stimulation (Fig. 6; A and B). In contrast, myosin IIB is localized to 
the cell cortex, and this pattern of localization was not altered upon insulin 
stimulation (Fig. 6; C and D). These results reveal first that there are distinct 
localization patterns of myosin II and that insulin signaling results in the 
recruitment of myosin IIA to the plasma membrane.
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Figure 6. The effect of insulin stimulation 
on myosin II localization in adipocytes. 3T3-
L1 adipocytes were treated according to the 
insulin stimulation protocol as described in 
materials and methods and the myosin II 
isoforms were visualized by 
immunofluorescence using either a myosin IIA 
or myosin IIB-specific antibody. Myosin IIA and 
myosin IIB localization was analyzed in the 
basal condition and after stimulation with 
insulin using confocal microscopy. The results 
are representative images from three 
independent experiments.
Myosin IIA is co-localized with GLUT4 vesicles at the plasma membrane after 
insulin stimulation in 3T3-L1 adipocytes
 In previous studies myosin II has been shown to play an important role in 
vesicle trafficking by interacting with filamentous actin [16, 17]. Recruitment of 
myosin IIA from the perinuclear region to the plasma membrane suggests that 
there may be an interaction between myosin II and the cortical layer of actin 
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found in 3T3-L1 adipocytes. Myosin II at the plasma membrane could possibly be 
involved in the rearrangement of the actin fibers to allow the GLUT4 - containing 
vesicles to properly dock and fuse with the plasma membrane. Since both 
myosin IIA and GLUT4 vesicles translocate to the plasma membrane upon 
insulin stimulation, it was of interest to determine whether GLUT4 and myosin IIA 
translocate to the same or different areas of the plasma membrane. 
 Confocal microscopy was used to verify the recruitment of myosin IIA and 
GLUT4 from the perinuclear region to the plasma membrane. The localization 
patterns of myosin IIA and GLUT4 during insulin stimulation in 3T3-L1 adipocytes 
was also identified. 
 In the basal state myosin IIA localized to the perinuclear region with 
GLUT4 (Fig. 7; A-C), localization of myosin IIA and GLUT4 is clearly indicated in 
the merged image by the yellow coloration at the perinuclear region. 
Insulin stimulation results in the translocation of myosin IIA and GLUT4 from the 
perinuclear region to specific regions of the plasma membrane (Fig 7; D and E). 
 The translocation of the two is indicated in the merged image (Fig. 7; F). 
The observed increase of yellow coloration at the plasma membrane indicates 
areas where myosin IIA and GLUT4 are localized at or near the same space. 
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Figure 7. The effect of insulin stimulation on myosin IIA and GLUT4 
localization in adipocytes. 3T3-L1 adipocytes were treated according to 
the insulin stimulation protocol as described in materials and methods. 
Myosin IIA and GLUT4 were visualized by immunofluorescence using
antibodies specific to myosin IIA and GLUT4 respectively. Myosin IIA and 
GLUT4 localization was analyzed in the basal condition and after
stimulation with insulin using confocal microscopy. The results are 
representative images from three independent experiments.
Basal
Insulin
MyoIIA GLUT4 Merge
 
Myosin IIA is recruited after GLUT4 vesicles to the plasma membrane during 
insulin stimulated glucose uptake
 Since both myosin IIA and GLUT4 are recruited from the perinuclear 
region upon insulin stimulation to specific points at the plasma membrane it is 
important to determine the timing of these events to answer which is recruited to 
the plasma membrane first.   
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Figure 8. Recruitment patterns of myosin IIA and GLUT4 during insulin 
stimulation . 3T3-L1 adipocytes were treated according to the time course 
insulin stimulation protocol as described in materials and methods. Myosin IIA 
and GLUT4 were visualized by immunofluorescence using antibodies specific 
to myosin IIA and GLUT4. Myosin IIA and GLUT4 localization was analyzed 
in the basal condition and after stimulation with insulin at 2,4,6 and 10 
minutes using confocal microscopy. The results are representative images 
from three independent experiments.
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Confocal microscopy was used to identify patterns of co-localization of 
myosin IIA and GLUT4 during a time course insulin stimulation assay. The 
localization of myosin II and GLUT4 were determined at 0, 2, 4, 6 and 10 minutes 
after insulin stimulation. 
Upon insulin stimulation, myosin IIA was recruited to the plasma 
membrane at approximately 4 minutes (Fig.8; 4 minutes). The amount of myosin 
IIA at the plasma membrane increased up to 10 minutes (Fig. 8; 6 and10 
minutes). The amount of GLUT4 increased from 2 minutes up to 10 minutes (Fig. 
8; 2-10 minutes). I have identified that myosin IIA is recruited after GLUT4 
containing vesicles have translocated to the plasma membrane and GLUT4 
recruitment was shown to be independent of the activity of myosin IIA. These  
findings suggest a role for myosin IIA in facilitating the fusion of GLUT4 vesicles 
at the plasma membrane.
 Recruitment of myosin IIA to the plasma membrane is regulated   
   by the insulin signaling pathway 
 Next, I examined how insulin was regulating the recruitment of myosin II to 
the plasma membrane by utilizing a series of inhibitors known to disrupt the 
activity of myosin II and the interaction of myosin II with actin. In my previous 
study I have shown that treating 3T3-L1 adipocytes with blebbistatin impaired 
insulin stimulated glucose uptake (Fig. 3) [1]. Blebbistatin inhibits the interaction 
of myosin II to actin by blocking the ATPase activity of myosin II. By blocking the 
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ATPase activity of myosin II it impairs the ability of myosin II to bind to 
filamentous actin. 
Temporal assays were performed and confocal microscopy was used to 
identify the patterns of localization of myosin IIA and GLUT4 during a time course 
insulin stimulation assay. The localization of myosin II and GLUT4 were 
determined at 0, 2, 4, 6 and 10 minutes after insulin stimulation. 
 I observed that the recruitment of myosin IIA from the perinuclear region to 
the plasma membrane was impaired in cells that had been treated with 
blebbistatin (Fig. 9; 4-10 minutes). At the 10 minute time point the level of myosin 
IIA at the plasma membrane was significantly lower than that observed in the 
insulin control (Fig. 8; 10 minutes). As indicated by the minimal change in yellow 
coloration observed at the plasma membrane in the blebbistatin treatment 
merged images that blebbistatin does in fact disrupt the recruitment of myosin IIA 
during insulin stimulated glucose uptake.   
 To identify how insulin was regulating the recruitment of myosin IIA 
another known inhibitor of myosin II activity was used. ML-7 inhibits the 
phosphorylation of the RLC of myosin II by impairing the activity MLCK. [10, 24, 
27 and 28]. 
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Figure 9. Treatment with blebbistatin impaired insulin 
stimulated recruitment of myosin IIA. 3T3-L1 adipocytes were 
incubated in the presence of blebbistatin and were treated 
according to the time course insulin stimulation protocol as 
described in materials and methods. Myosin IIA and GLUT4 were 
visualized by immunofluorescence using antibodies specific to 
myosin IIA and GLUT4. Myosin IIA and GLUT4 localization was 
analyzed in the basal condition and after stimulation with insulin at 
2,4,6 and 10 minute time points using confocal microscopy. The 
results are representative images from three independent 
experiments.
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Figure 10. Treatment with ML-7 impaired insulin stimulated 
myosin IIA recruitment. 3T3-L1 adipocytes were incubated in the 
presence of ML-7 and were treated according to the time course 
insulin stimulation protocol as described in materials and methods. 
Myosin IIA and GLUT4 were visualized by immunofluorescence using
antibodies specific to myosin IIA and GLUT4. Myosin IIA and GLUT4 
co-localization was analyzed in the basal condition and after 
stimulation with insulin at 2,4,6 and 10 minute time points using 
confocal microscopy. The results are representative images from three 
independent experiments.
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Temporal assays were performed and confocal microscopy was used to 
identify patterns of co-localization of myosin IIA and GLUT4 during a time course 
insulin stimulation assay. The localization of myosin II and GLUT4 were 
determined at 0, 2, 4, 6 and 10 minutes after insulin stimulation using confocal 
microscopy. 
 I observed that myosin IIA remained localized at the perinuclear 
region in cells that had been treated with ML-7 (Fig. 10; Myosin IIA panel). These 
patterns are consistent with the basal controls seen in Fig. 8; A - C. Inhibition of 
myosin IIA activity did not affect the translocation of GLUT4 containing vesicles 
to the plasma membrane (Fig. 10; GLUT4 panel). In the merged images of the 
ML-7 treatment there is significantly less co-localization of myosin IIA and GLUT4 
at ten minutes due to the inhibition of myosin II activation. This is indicated by the 
low levels of yellow coloration observed at the plasma membrane. This indicates 
that myosin IIA and GLUT4 are not co-localized at the plasma membrane (Fig. 
10; 10 minutes). 
In this investigation I have revealed that stimulating 3T3-L1 adipocytes 
with insulin resulted in the recruitment of myosin IIA to the plasma membrane 
from the perinuclear region. I have shown that chemical inhibition of the 
activation of myosin II resulted in a disruption of the dynamic recruitment of 
myosin IIA to the plasma membrane and this inhibition resulted in impaired 
insulin stimulated glucose uptake [1] (Fig. 3). Translocation of GLUT4 to the 
plasma membrane was shown to be independent of myosin II activity (Fig.; 6 - 
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10). Inhibiting myosin II activity by inhibiting the phosphorylation of the RLC 
resulted in myosin IIA remaining at the perinuclear region rather than 
translocating to the plasma membrane. These results indicate that the 
recruitment of myosin IIA to the plasma membrane is regulated via myosin light 
chain kinase. It is important to directly determine if the phosphorylated state of 
the RLC of myosin IIA is being regulated by insulin.
Myosin IIA is activated during insulin stimulated glucose uptake
 My results have thus far identified that the myosin II isoforms IIA and IIB 
do exhibit distinct patterns of localization and recruitment during insulin 
stimulated glucose uptake in 3T3-L1 adipocytes. Since these patterns were 
identified it was important to identify which of the two myosin II isoforms is being 
activated by insulin. Myosin II motor activity and parallel filament assembly are 
regulated by the phosphorylation of residues localized on the RLC [5, 10]. 
Detection of the phosphorylated RLC was used to indicate which isoforms are 
active during insulin stimulated glucose uptake.  
 To determine if myosin IIA, myosin IIB or both, are activated during insulin 
stimulation, cells were incubated in the presence of DMSO, DMSO and insulin or 
insulin and either blebbistatin or ML-7. The cells were lysed and the lysates were 
collected for use in immunoprecipitation assays. Antibodies specific to myosin 
IIA, myosin IIB, RLC or the phosphorylated RLC were used to immunoprecipitate 
their respective antigen from the collected lysates. All of the immunoprecipitates 
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were also immunoblotted and probed with each of the antibodies used in this 
investigation as a control to verify immunoprecipitation and to identify any cross 
reactivity. 
Figure 11. Effect of insulin 
stimulation on the activation of
myosin IIA and myosin IIB. 3T3-L1 
adipocytes were treated according to 
the insulin stimulation protocol as 
described in materials and methods. 
Cell lysates were immunoprecipitated 
with antibodies specific to A. myosin 
IIA or B. myosin IIB. 
Immunoprecipitates were resolved by 
SDS-PAGE and then probed with 
antibodies against myosin IIA, myosin 
IIB, RLC or Phosphorylated-RLC. The 
results are representative of three 
independent experiments.
A. MyoIIA
Insulin
RLC
P-RLC
- +
MyoIIBB.
RLC
P-RLC
 I observed that the RLC associated with myosin IIA was phosphorylated in 
cells stimulated with insulin. In the presence of insulin myosin IIA was shown to 
have a significant increase in the amount of phosphorylated RLC as compared to 
the basal controls (Fig. 11).
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Figure 12. Inhibiting the activity of myosin II affects the 
phosphorylation status of the RLC.. 3T3-L1 adipocytes 
were pre-treated with 100 µM blebbistatin or 10 µM ML-7 
for four hours and  then treated according to the insulin 
stimulation protocol as described in materials and methods. 
Cell lysates were then immunoprecipitated with antibodies 
specific to myosin IIA. Immunoprecipitates were resolved by 
SDS-PAGE and then probed with antibodies against 
phosphorylated-RLC. The results are representative of 
three independent experiments.
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 In 3T3-L1 adipocytes treated with blebbistatin plus insulin the amount of 
phosphorylated RLC observed in myosin IIA was relatively unaffected compared 
to the insulin only control (Fig. 12). A decrease in the amount of phosphorylated 
RLC was observed in myosin IIA in cells treated with ML-7 plus insulin compared 
to the insulin only control (Fig. 12). 
 I have identified that myosin IIA and myosin IIB are both expressed in 
3T3-L1 adipocytes and that these isoforms exhibit distinct patterns of localization 
following those observed in other cell types where myosin IIA localizes to 
dynamic regions of cells / tissues. I have also shown that myosin IIA is actively 
recruited from the perinuclear region to areas at the plasma membrane 
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containing GLUT4 in 3T3-L1 adipocytes (Fig.; 7-9). The results from the 
immunoprecipitation assays indicate that myosin IIA is activated during insulin 
stimulation by phosphorylation of the RLC. It is shown that by inhibiting the 
interaction of myosin II with actin with blebbistatin results in no significant change 
in the phosphorylation status of myosin IIA RLC. Inhibiting the activation of 
myosin II in a MLCK dependent manner results in an observed decrease of 
phosphorylated RLC detected in myosin IIA. These results demonstrate that the 
activation and subsequent recruitment of myosin IIA to the plasma membrane in 
3T3-L1 adipocytes is regulated by insulin. These results provide support for my 
hypothesis that the localization and activation of myosin II isoforms are regulated 
by insulin during insulin stimulated glucose uptake in 3T3-L1 adipocytes.
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CHAPTER IV
DISCUSSION
The purpose of this study was to test for a potential role of myosin II in 
insulin stimulated glucose uptake. This was dond by determining the localization 
patterns of myosin II isoforms in 3T3-L1 adipocytes during insulin stimulation and 
to determine whether the recruitment of myosin II was regulated by insulin. I have 
shown that in 3T3-L1 adipocytes myosin IIA is localized to the perinuclear region 
in the basal state and is recruited to the plasma membrane after stimulation with 
insulin (Fig 6; A and B; Fig 7; A and D). Myosin IIB was shown to remain 
localized at the plasma membrane in 3T3-L1 adipocytes in the basal state and 
throughout the process of insulin stimulated glucose uptake (Fig. 6; C and D). 
The results presented in this study indicate that myosin IIA may be recruited in 
an insulin dependent manner to the plasma membrane to initiate the process of 
reorganizing the cortical layer of actin found in 3T3-L1 adipocytes.  
This report identifies the same recruitment pattern of cytoplasmic myosin 
IIA to dynamic areas as previously identified in gastric parietal cells lamellipodial 
extensions via histamine stimulation [37]. The recruitment patterns of myosin IIA 
identified in various cell types including 3T3-L1 adipocytes put myosin IIA at 
areas in which cytoskeletal components are being altered or rearranged. 
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I hypothesized that myosin IIA is dynamically or actively recruited to the 
plasma membrane. M y data indicates that by treating cells with the myosin II 
specific inhibitor blebbistatin, myosin IIA remained localized to the perinuclear 
region in adipocytes while the recruitment of GLUT4 to the plasma membrane 
was unaffected (Fig. 9). Blebbistatin blocks the ATPase activity of myosin II  and 
its interaction with actin and results in active myosin IIA remaining localized at 
the perinuclear region of adipocytes. Inhibition of myosin II activity associated 
with actin resulted in a significant impairment of insulin stimulated glucose uptake 
as reported in my previous study [1]. By revealing that the inhibition of myosin II 
ATPase activity affects the recruitment of actin-associated myosin IIA to the 
plasma membrane, it was important to identify if only active, phosphorylated 
myosin IIA was recruited to the plasma membrane upon insulin stimulation. By 
treating cells with the MLCK specific inhibitor ML-7, it was shown that the 
recruitment of myosin IIA to the plasma membrane was greatly impaired although 
the level of GLUT4 vesicles recruited to the plasma membrane was not (Fig.9 
and Fig. 10). This indicates that only active myosin IIA that is associated with 
actin is recruited to the plasma membrane and that the recruitment of GLUT4 is 
independent of the activity of myosin IIA. These results taken together suggest 
that inhibiting the recruitment of active myosin IIA to the plasma membrane or 
that inhibiting the association of myosin IIA with actin impairs glucose uptake.  
Investigation of the patterns of co-localization of myosin IIA and GLUT4 in 
3T3-L1 adipocytes revealed that in the basal state, myosin IIA and GLUT4 were 
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found to be co-localized at the perinuclear region (Fig. 7; A-C). Upon insulin 
stimulation, active myosin IIA was recruited to specific regions where GLUT4 had 
translocated to at the plasma membrane in adipocytes (Fig. 7; D-F). These 
results are the first to identify that myosin IIA co-localizes with GLUT4 to specific 
regions at the plasma membrane in 3T3-L1 adipocytes. It was shown that by 
inhibiting both the interaction of myosin II with actin and also by inhibiting the 
phosphorylation of the RLC, myosin IIA remained localized at the perinuclear 
region of 3T3-L1 adipocytes. In these treatments GLUT4 was shown to 
translocate to the plasma membrane with no co-localization of myosin IIA at the 
plasma membrane (Fig. 7). This result indicates that both the interaction of 
myosin IIA with actin and the phosphorylation of the RLC of myosin IIA is 
required for its recruitment to the plasma membrane during insulin stimulated 
glucose uptake. 
The results in this study have identified that the recruitment of myosin IIA 
is independent of GLUT4 translocation to the plasma membrane during insulin 
stimulation. With this pattern revealed it was important to identify when myosin 
IIA is recruited to the plasma membrane in relation to the recruitment of GLUT4 
during insulin stimulation. A temporal relationship of the recruitment pattern of 
myosin IIA and GLUT4 was identified in 3T3-L1 adipocytes.GLUT4 translocated 
to the plasma membrane prior to myosin IIA after insulin stimulation (Fig. 8). 
Results from my previous study show that by treating adipocytes with blebbistatin 
insulin stimulated glucose uptake was impaired in 3T3-L1 adipocytes (Fig. 3 and 
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Fig. 8) [1]. The results presented in this report identify that GLUT4 levels at the 
plasma membrane increase up to the 10 minute time point although the 
recruitment of active myosin IIA to the plasma membrane was impaired 
Since myosin IIA is actively recruited to the plasma membrane it was 
important to identify if this recruitment was dependent upon the activation of 
myosin IIA. Previous studies have shown that myosin IIA can be recruited to 
areas where distinct cellular processes are occurring without being activated via 
phosphorylation of the RLCs as seen in the recruitment of inactive myosin IIA to 
the furrow of dividing HeLa cells [38]. Activation of myosin IIA was inhibited using 
ML-7 in that study. These studies resulted in myosin IIA remaining localized at 
the perinuclear region during insulin stimulation since non-active myosin II cannot 
interact with actin (Fig. 9). The levels of GLUT4 recruited to the plasma 
membrane were shown to be unaffected by inhibiting the activation of myosin IIA 
(Fig. 9). These results indicate that the activation of myosin IIA is also required 
for its recruitment to the plasma membrane. Thus far I have identified that the 
recruitment of myosin IIA is independent of the translocation of GLUT4 to the 
plasma membrane in 3T3-L1 adipocytes. I have also revealed that myosin IIA 
translocates and co-localizes to specific areas at the plasma membrane where 
GLUT4 is localized. Furthermore, I have identified that by inhibiting both myosin 
IIA activity and its association with actin results in myosin IIA remaining localized 
at the perinuclear region in 3T3-L1 adipocytes. These results further support the 
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idea that the recruitment of myosin IIA is dependent upon its activity and 
association with actin in 3T3-L1 adipocytes.  
Since the recruitment of myosin IIA is dependent upon its activity and the 
recruitment of active myosin IIA is dependent upon its association with actin; it 
was important to identify the activation patterns of myosin II during insulin 
stimulated glucose uptake. I identified that the activation of myosin IIA is 
regulated by insulin signaling. Activation was determined by assaying the P- RLC 
of myosin IIA after insulin stimulation. RLC phosphorylation was increased only in 
the presence of insulin (Fig. 11 and Fig. 12). Treating cells with the chemical 
inhibitor blebbistatin resulted in levels of phosphorylated RLC comparable to that 
seen in the insulin controls (Fig. 12). These results show that inhibiting the 
ATPase activity of myosin IIA pharmacologically does not inhibit the activation of 
myosin IIA but does inhibit its active recruitment to the plasma membrane in 3T3-
L1 adipocytes. I have identified that by inhibiting of the activation of myosin IIA by 
inhibiting MLCK results in a decrease of phosphorylated RLC (Fig.12).  These 
results further support the results from my confocal microscopy studies indicating 
that the recruitment of myosin IIA to the plasma membrane is dependent upon its 
activation.  
The results from this study are the first to identify that myosin IIA activity 
and association with actin are dependent on insulin. Continuation of these 
studies is important to reveal the details regulating this interaction involving 
myosin II, GLUT4 and actin. Revealing the underlying interactions and 
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mechanisms affecting insulin stimulated glucose uptake may provide important 
information that could be used to optimize current treatments or develop new 
treatments for type II diabetes. 
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